Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
developed a DVT shortly after having the vaccine; This is a spontaneous report received from a Consumer or other non HCP. A 38-year-old male patient received BNT162b2 (BNT162B2), on 15Apr2021 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 38 years, in arm (shoulder) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DEEP VEIN THROMBOSIS (medically significant) with onset 15Apr2021 at 12:00, outcome "not recovered", described as "developed a DVT shortly after having the vaccine". The patient underwent the following laboratory tests and procedures: Ultrasound scan: unknown results. Therapeutic measures were taken as a result of deep vein thrombosis and included blood thinners. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Test Name: Ultrasound; Result Unstructured Data: Test Result:unknown results